| Expression pattern: |
UP |
| Associated gene: |
IGF2R |
| Associated microRNA: |
hsa-miR-361-3p |
| Biological function: |
Promotes bladder cancer cell proliferation, migration, invasiveness, tumor growth and metastasis; promotes autophagy. |
| Molecular mechanism: |
Acts as a ceRNA by sponging hsa-miR-361-3p to regulate IGF2R expression, affecting autophagy and tumor progression. |
| Biological pathway or process: |
autophagy (promotes); proliferation (promotes); migration (promotes); invasion (promotes); metastasis (promotes); ceRNA regulation (promotes) |
| Detected method: |
Q
H
S
|
| Validation methods: |
RNA-seq; RT-qPCR; RNase R Treatment; FISH / smFISH; Clinical Sample Validation; Survival Analysis; Transfection; CCK8; Colony Formation Assay; Wound Healing Assay; Transwell Assay; In Vivo Animal Model; IHC (Immunohistochemistry); H&E Staining; RNA Pull-Down; Luciferase Reporter Assay; Western Blot; IF (Immunofluorescence) |
| Clinical significance: |
High hsa_circ_0007813 expression was associated with larger tumor size, higher primary tumor T stage, higher pathologic grade, and poorer prognosis. |
| Description: |
hsa_circ_0007813 is up-regulated in bladder cancer and predicts worse overall survival. It promotes proliferation, migration/invasion, tumor growth and metastasis, and regulates autophagy by sponging hsa-miR-361-3p to increase IGF2R expression. |
| Confidence score: |
0.831 |